Settings
ENDP [NASD]
Endo International plc
Index- P/E- EPS (ttm)-11.05 Insider Own0.50% Shs Outstand153.91M Perf Week-1.05%
Market Cap12.18B Forward P/E17.23 EPS next Y4.60 Insider Trans0.00% Shs Float150.54M Perf Month10.30%
Income-1296.20M PEG- EPS next Q1.11 Inst Own- Short Float13.08% Perf Quarter22.41%
Sales2.50B P/S4.86 EPS this Y21.20% Inst Trans0.22% Short Ratio8.38 Perf Half Y15.50%
Book/sh16.25 P/B4.87 EPS next Y8.42% ROA-15.80% Target Price78.53 Perf Year20.38%
Cash/sh4.64 P/C17.07 EPS next 5Y6.22% ROE-65.70% 52W Range53.62 - 82.16 Perf YTD9.75%
Dividend- P/FCF76.09 EPS past 5Y-33.80% ROI-8.50% 52W High-2.99% Beta1.19
Dividend %- Quick Ratio1.10 Sales past 5Y15.70% Gross Margin54.70% 52W Low48.64% ATR2.09
Employees3371 Current Ratio1.30 Sales Q/Q15.50% Oper. Margin19.40% RSI (14)62.20 Volatility2.53% 2.59%
OptionableYes Debt/Eq1.76 EPS Q/Q-456.50% Profit Margin-57.60% Rel Volume1.51 Prev Close79.15
ShortableYes LT Debt/Eq1.69 EarningsFeb 26 BMO Payout- Avg Volume2.35M Price79.70
Recom2.10 SMA203.74% SMA509.24% SMA20017.14% Volume3,354,029 Change0.69%
Sep-02-14Initiated RBC Capital Mkts Outperform $80
Aug-01-14Reiterated Stifel Buy $75 → $84
Jun-27-14Initiated Canaccord Genuity Buy $83
Apr-30-14Initiated National Alliance Securities Buy $76
Mar-04-14Reiterated FBR Capital Mkt Perform $52 → $82
Mar-03-14Reiterated UBS Buy $75 → $90
Nov-06-13Upgrade Needham Underperform → Hold
Nov-06-13Reiterated Stifel Buy $40 → $60
Oct-30-13Initiated FBR Capital Mkt Perform $40
Sep-20-13Reiterated UBS Buy $43 → $50
Jun-21-13Resumed Oppenheimer Perform
Jun-06-13Reiterated UBS Buy $39 → $41
Jun-06-13Reiterated Stifel Buy $36 → $40
Jun-06-13Downgrade Cantor Fitzgerald Hold → Sell $36 → $30
May-13-13Reiterated Stifel Buy $42 → $36
May-08-13Reiterated RBC Capital Mkts Underperform $28 → $29
Apr-17-13Reiterated Stifel Buy $38 → $42
Apr-10-13Downgrade Standpoint Research Buy → Hold
Jan-31-13Reiterated Cantor Fitzgerald Hold $26 → $34
Jan-31-13Downgrade Oppenheimer Outperform → Perform
Jan-23-15 07:00AM  Endo International plc (ENDP): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report Zacks
Jan-22-15 05:10PM  Endo Prices $1.2B Senior Notes Offering for Auxilium Deal - Analyst Blog Zacks
11:10AM  Big payday looming for Auxilium executives at American City Business Journals
Jan-21-15 05:58PM  Endo International Set to Join the S&P 500; Boston Beer to Join S&P MidCap 400; Southside Bancshares to Join S&P SmallCap 600 PR Newswire
05:31PM  Endo International Tapped to Join S&P 500 at Barrons.com
02:00PM  ARIAD's Iclusig Endorsed by EC for All Approved Indications - Analyst Blog Zacks
09:30AM  Zacks.com featured expert Kevin Matras highlights: Endo International, Vulcan Materials, Ambarella, Jones Lang LaSalle and Skullcandy - Press Releases Zacks
08:17AM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:00AM  Endo International plc Announces Pricing of Private Offering Of Senior Notes PR Newswire
08:00AM  Endo International plc Announces Pricing of Private Offering Of Senior Notes CNW Group
Jan-20-15 06:12PM  Evotec Signs New Deal for Addictive Disorder Therapies - Analyst Blog Zacks
03:15PM  Endo Limited -- Moody's rates Endo's new senior notes B1; stable outlook at Moody's
02:10PM  Novo Nordisk's Xultophy to Launch First in Switzerland - Analyst Blog Zacks
08:45AM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
08:30AM  Endo International plc Announces Proposed Private Offering Of Senior Notes PR Newswire
08:30AM  Endo International plc Announces Proposed Private Offering Of Senior Notes CNW Group
01:00AM  Get Ready To Be Surprised This Earnings Season - Screen of the Week Zacks
Jan-19-15 04:10PM  OncoGenex's AFFINITY on Track, Passes Futility Analysis - Analyst Blog Zacks
02:10PM  UCB-Neuropore Collaborate for Parkinson's Disease Therapy - Analyst Blog Zacks
Jan-15-15 05:17PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibi EDGAR Online
02:42PM  Endo Finance LLC -- Moody's confirms Endo at Ba3; stable outlook at Moody's
02:00PM  BioCryst's BCX4161 Recommended for Orphan Drug in EU - Analyst Blog Zacks
Jan-14-15 06:05PM  ARIAD Reveals 2015 Strategic Objectives, Updates on Pipeline - Analyst Blog Zacks
Jan-09-15 10:27AM  Endo changing its management structure at American City Business Journals
08:00AM  Endo Announces Changes to Senior Management Team PR Newswire
08:00AM  Endo Announces Changes to Senior Management Team CNW Group
Jan-08-15 04:20PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibi EDGAR Online
Jan-05-15 04:30PM  Endo Announces Retirement of Chief Legal Officer PR Newswire
04:30PM  Endo Announces Retirement of Chief Legal Officer CNW Group
Jan-01-15 10:20AM  Glenview Capital raises position in Endo International Market Realist
Dec-26-14 06:20PM  Stock Market Video Analysis for Week Ending 12/26/14 Yahoo Finance Blogs
Dec-24-14 05:10PM  For this drug developer, 2014 was 'best year in company history' at bizjournals.com
12:35PM  New chronic pain treatment could soon be available thanks to Raleigh drug developer at bizjournals.com
Dec-23-14 03:42PM  Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain PR Newswire
03:42PM  Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain CNW Group
Dec-22-14 04:01PM  Endo Announces Appearances at Upcoming Conferences PR Newswire
04:01PM  Endo Announces Appearances at Upcoming Conferences CNW Group
Dec-12-14 12:01AM  Bard Judge Says Implant Maker Facing Billions in Verdicts at Bloomberg
Dec-11-14 05:00PM  Endo Registration Statement Relating to Pending Auxilium Acquisition Declared Effective by the SEC PR Newswire
05:00PM  Endo Registration Statement Relating to Pending Auxilium Acquisition Declared Effective by the SEC CNW Group
Dec-09-14 07:00AM  Endo Completes Acquisition of Rights to Natesto Testosterone Nasal Gel PR Newswire
07:00AM  Endo Completes Acquisition of Rights to Natesto Testosterone Nasal Gel CNW Group
Dec-03-14 02:06PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online
Nov-24-14 07:00AM  Endo Acquires Rights to Natesto Testosterone Nasal Gel PR Newswire
07:00AM  Endo Acquires Rights to Natesto Testosterone Nasal Gel CNW Group
Nov-20-14 09:57AM  U.S. court denies Ranbaxy's bid to block launch of rival generics Reuters
07:30AM  Endo Announces Launch of Generic Version of Valcyte® PR Newswire
07:30AM  Endo Announces Launch of Generic Version of Valcyte® CNW Group
Nov-19-14 07:30AM  Endo Announces Early Termination of HSR Act Waiting Period in Connection with its Proposed Acquisition of Auxilium Pharmaceuticals PR Newswire
Nov-18-14 01:04PM  ENDO INTERNATIONAL PLC Financials EDGAR Online Financials
10:01AM  Endo International (ENDP) Strong On High Relative Volume Today at TheStreet
Nov-10-14 05:10PM  ENDO INTERNATIONAL PLC Files SEC form 10-Q, Quarterly Report EDGAR Online
09:54AM  Dr. Reddy's Laboratories: The Bridge to 2016 at Barrons.com
08:00AM  Endo Receives Final Approval for Generic Version of Valcyte® PR Newswire
05:38AM  La Jolla Pharmaceutical (LJPC) in Focus: Stock Surges 10.2% Zacks
Nov-07-14 05:44AM  Dr Reddy's gets FDA approval for Roche drug generic; shares at record high Reuters
Nov-06-14 11:26PM  Dr Reddy's, Endo get FDA approval to launch generic Valcyte Reuters
08:30AM  Endo International Beats on Q3 Earnings & Sales, View Up Zacks
Nov-05-14 04:29PM  New balance of power on Capitol Hillbut no change in stock prices Yahoo Finance Blogs
12:28PM  Endo raises 2014 outlook again, Q3 profit beats Street Reuters
10:29AM  Endo International (ENDP) Is Today's Water-Logged And Getting Wetter Stock at TheStreet
09:00AM  Endo International PLC Earnings Call scheduled for 9:00 am ET today CCBN
08:46AM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online
07:22AM  Endo profit beats estimates on strong generic drug sales Reuters
07:07AM  Q3 2014 Endo International PLC Earnings Release - Before Market Open CCBN
07:00AM  Endo Reports Third Quarter Financial Results PR Newswire
Nov-04-14 11:50AM  Zoetis Q3 Earnings Beat Driven by Higher Livestock Sales Zacks
Oct-31-14 02:08PM  Contrarian fund manager's top 3 stock picks at CNBC
12:07PM  Contrarian picks: UAL, LE & ENDP CNBC
Oct-29-14 11:14AM  3 Health Care Picks To Beat Earnings Zacks
08:15AM  Analysts Top 4 Specialty Pharmaceutical Stocks to Buy Before Earnings at 24/7 Wall St.
Oct-20-14 04:00PM  Endo to Announce Third Quarter 2014 Financial Results on November 5, 2014 PR Newswire
Oct-14-14 03:51PM  Sterne Agee Sees Entry Point In Endo International PLC Shares Benzinga
12:01AM  [$$] BioDelivery Sciences May Deliver Less at Barrons.com
Oct-13-14 10:33PM  AUXILIUM PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Auxilium Pharmaceuticals, Inc. PR Newswire
12:42PM  How Will Endo International (ENDP) Stock Be Affected Today by This Analyst Action? at TheStreet
08:00AM  Top Analyst Upgrades and Downgrades: Cliffs, CME, Darden, Endo, J.C. Penney and More at 24/7 Wall St.
Oct-10-14 05:37PM  Inversion Vitriol Vs. Drug Consolidation Investor's Business Daily
04:45PM  Endo to Buy Auxilium for $2.6B, Diversify Portfolio Zacks
02:56PM  UPDATE: Mizuho Securities Downgrades Auxilium Pharmaceuticals Benzinga
06:47AM  The Morning Ledger: Early Inversion Deal Makers Come Back for More at The Wall Street Journal
Oct-09-14 11:58PM  [$$] Tax-Inversion Players Swoop In for Seconds at The Wall Street Journal -5.94%
07:00PM  Endo Buyout Of Auxilium Joins Two Changing Firms at Investor's Business Daily
05:23PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statem EDGAR Online
04:55PM  Dow Suffers Worst One-Day Performance In 2014, Volatility Returns To The Markets Benzinga
02:54PM  Endo bolsters men's healthcare business with Auxilium deal Reuters
01:53PM  How Endo International's $2.6B Deal for Auxilium Benefits Shareholders at TheStreet
09:42AM  [$$] Endo International to Buy Auxilium at The Wall Street Journal
09:32AM  [video] Endo buys Auxilium Pharma at CNBC
09:19AM  Morning Movers: Gap Tumbles on CEO Retirement; Pepsi Pops on Earnings at Barrons.com
09:10AM  Stock Futures Down, Off Lows; Alcoa, United, Auxilium Rise at Investor's Business Daily
08:37AM  Endo Intl to buy Auxilium in deal worth $2.6B AP
08:15AM  US STOCKS-Futures turn lower as global growth concerns weigh Reuters
07:56AM  US STOCKS-Results boost Alcoa, PepsiCo in premarket trading Reuters
07:41AM  Early Movers: PEP, AUXL, ENDP, HLT, MW, RT & more at CNBC
07:02AM  Endo Reaches Deal to Buy Auxilium Pharmaceuticals for $2.6B at TheStreet
06:53AM  Endo to buy Auxilium for $2.6 bln, Auxilium drops QLT deal Reuters
06:48AM  Endo Agrees to Buy Auxilium for $2.6 Billion at Bloomberg
06:30AM  Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion PR Newswire
Oct-06-14 05:15PM  Mylan Surges on Improved Q3 and Full-Year Earnings Outlook Zacks
Endo International plc, a specialty healthcare company, develops, manufactures, markets, and distributes branded pharmaceutical and generic products, and medical devices worldwide. It provides branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar, and Fortesta Gel to treat and manage pain and conditions in urology, endocrinology, and oncology. The company also offers non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets; and pharmaceutical products in the areas of ADHD, pain, urology, and allergy. In addition, it provides various medical devices comprising AMS 700 MS series, AMS 800 artificial urinary sphincters, GreenLight XPS laser systems, Elevate anterior and posterior pelvic floor repair systems, and Monarc subfascial hammock products in the areas of men's and women's health, and prostate health. The company's products also include Aveed, an injectable testosterone preparation to treat male hypogonadism; and BEMA Buprenorphine, a transmucosal form of buprenorphine in Phase III trials for treating moderate to severe chronic pain. It serves pharmacy chains directly; and hospitals, governmental agencies, pharmacies, and physicians through wholesale drug distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.